Fröhlich, Fabienne
Micheroli, Raphael http://orcid.org/0000-0002-8918-7304
Hebeisen, Monika
Kissling, Seraphina http://orcid.org/0000-0003-0619-0012
Bürki, Kristina
Exer, Pascale
Bräm, René
Niedermann, Karin
Möller, Burkhard
Nissen, Michael J.
Kyburz, Diego
Andor, Michael
Distler, Oliver
Scherer, Almut
Ciurea, Adrian http://orcid.org/0000-0002-7870-7132
Funding for this research was provided by:
Zurich University Foundation
University of Zurich
Article History
Received: 21 May 2022
Revised: 14 December 2022
Accepted: 16 December 2022
First Online: 27 December 2022
Declarations
:
: The study has been approved by the Ethics Commission of the Canton of Zurich (KEK-ZH-Nr. 2014-0439) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Written informed consent was obtained from all patients.
: AC received honoraria for lectures from AbbVie, Merck Sharp & Dohme, and Novartis. AS received consulting fees from Pfizer and support for attending meetings from Gilead. BM received speaking fees from Jansen and Novartis and support for attending meetings from Pfizer (payments to institution). DK received consulting and/or speaking fees from Abbvie, Gilead, Eli Lilly, Novartis, and Pfizer. MJN received consulting and/or speaking fees from Abbvie, Celgene, Eli Lilly, Novartis, and Pfizer. OD received consulting and/or speaking fees from Abbvie, Amgen, Eli Lilly, and Pfizer. RM received consulting and/or speaking fees from Abbvie, Eli Lilly, Gilead, and Pfizer. FF, KB, KN, MA, MH, RB, and SK declare they have no conflicts of interest.